Related Experiment Video
Updated: Jun 7, 2025

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
Prevalence of cardiometabolic diseases in underweight: a nationwide cross-sectional study
Meng Chen1, Shuxiao Shi1, Sujing Wang1
1Department of Epidemiology and Biostatistics, School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai200025, People's Republic of China.
Insights
Nearly half of US adults with underweight have cardiometabolic diseases (CMD). A significant 12.3% have two or more CMD, highlighting a critical public health challenge.
Area of Science:
- Public Health
- Cardiology
- Endocrinology
Background:
- Cardiometabolic diseases (CMD) pose a significant health burden.
- Underweight individuals are often overlooked in CMD prevalence studies.
- Understanding CMD prevalence in underweight populations is crucial for targeted interventions.
Purpose of the Study:
- To estimate the nationwide prevalence of various cardiometabolic diseases (CMD) among adults with underweight in the US.
- To assess the prevalence of zero or at least two CMD in this population.
- To identify potential disparities in CMD prevalence among different demographic subgroups.
Main Methods:
- Utilized data from the National Health and Nutrition Examination Survey (1999-2020).
- Estimated age-standardized prevalence of dyslipidemia, hypertension, diabetes, chronic kidney disease, and cardiovascular disease (CVD).
- Employed multivariable Poisson regressions to compare CMD prevalence across subgroups, adjusting for covariates.
Main Results:
- Among 855 underweight adults, 23.4% had dyslipidemia, 15.6% hypertension, 2.5% diabetes, 7.9% chronic kidney disease, and 6.1% CVD.
- 50.6% had zero CMD, while 12.3% had at least two CMD.
- Non-Hispanic Black adults showed a significantly higher prevalence of diabetes compared to non-Hispanic White adults.
Conclusions:
- Approximately half of US adults with underweight have at least one CMD.
- A notable 12.3% of underweight adults have two or more CMD, indicating a substantial disease burden.
- The prevention and management of CMD in underweight adults represent a critical, yet often neglected, public health issue.
Abstract:
This study aimed to estimate the nationwide prevalence of cardiometabolic diseases (CMD) among adults with underweight in the US general population. Using data from the National Health and Nutrition Examination Survey (1999-2020), we estimated the age-standardised prevalence of dyslipidemia, hypertension, diabetes, chronic kidney disease, CVD and the presence of zero or at least two CMD. Multivariable Poisson regressions were used to compare CMD prevalence between subgroups, adjusting for age, sex and race/ethnicity. Among the 855 adults with underweight included, the weighted mean age was 40·8 years, with 68·1 % being women and 70·4 % non-Hispanic White. The estimated prevalence rates were 23·4 % for dyslipidemia (95 % CI 19·4 %, 27·5 %), 15·6 % for hypertension (95 % CI 13·3 %, 17·8 %), 2·5 % for diabetes (95 % CI 1·5 %, 3·5 %), 7·9 % for chronic kidney disease (95 % CI 6·9 %, 8·8 %) and 6·1 % for CVD (95 % CI 4·3 %, 7·9 %). The prevalence of having zero and at least two CMD was 50·6 % (95 % CI 44·1 %, 57·0 %) and 12·3 % (95 % CI 8·1 %, 16·4 %), respectively. Non-Hispanic Black adults had significantly higher prevalence of diabetes (adjusted prevalence ratio, 3·35; 95 % CI 1·35, 8·30) compared with non-Hispanic White adults. In conclusion, approximately half of the underweight adults had at least one CMD, and 12·3 % had at least two CMD. Prevention and management of CMD in underweight adults are critical yet neglected public health challenges.
More Related Videos
Related Concept Videos
Obesity
Metabolic States of the Body: Fasting and Starvation
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Anorexia Nervosa
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

